Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

James Krempski, Lavakumar Karyampudi, Marshall D. Behrens, Courtney L. Erskine, Lynn Hartmann, Haidong M Dong, Ellen L Goode, Kimberly R. Kalli, Keith L Knutson

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Within the ovarian cancer microenvironment, there are several mechanisms that suppress the actions of antitumor immune effectors. Delineating the complex immune microenvironment is an important goal toward developing effective immune-based therapies. A dominant pathway of immune suppression in ovarian cancer involves tumor-associated and dendritic cell (DC)-associated B7-H1. The interaction of B7-H1 with PD-1 on tumor-infiltrating T cells is a widely cited theory of immune suppression involving B7-H1 in ovarian cancer. Recent studies suggest that the B7-H1 ligand, programmed death receptor-1 (PD-1), is also expressed on myeloid cells, complicating interpretations of how B7-H1 regulates DC function in the tumor. In this study, we found that ovarian cancer-infiltrating DCs progressively expressed increased levels of PD-1 over time in addition to B7-H1. These dual-positive PD-1+ B7-H1 + DCs have a classical DC phenotype (i.e., CD11c +CD11b+CD8-), but are immature, suppressive, and respond poorly to danger signals. Accumulation of PD-1+B7-H1 + DCs in the tumor was associated with suppression of T cell activity and decreased infiltrating T cells in advancing tumors. T cell suppressor function of these DCs appeared to be mediated by T cell-associated PD-1. In contrast, ligation of PD-1 expressed on the tumor-associated DCs suppressed NF-κB activation, release of immune regulatory cytokines, and upregulation of costimulatory molecules. PD-1 blockade in mice bearing ovarian cancer substantially reduced tumor burden and increased effector Ag-specific T cell responses. Our results reveal a novel role of tumor infiltrating PD-1 +B7-H1+ DCs in mediating immune suppression in ovarian cancer.

Original languageEnglish (US)
Pages (from-to)6905-6913
Number of pages9
JournalJournal of Immunology
Volume186
Issue number12
DOIs
StatePublished - Jun 15 2011

Fingerprint

Death Domain Receptors
Ovarian Neoplasms
Dendritic Cells
T-Lymphocytes
Neoplasms
Tumor Microenvironment
Myeloid Cells
Antigen-Antibody Complex
Tumor Burden
Ligation
Up-Regulation
Cytokines
Ligands
Phenotype

ASJC Scopus subject areas

  • Immunology

Cite this

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. / Krempski, James; Karyampudi, Lavakumar; Behrens, Marshall D.; Erskine, Courtney L.; Hartmann, Lynn; Dong, Haidong M; Goode, Ellen L; Kalli, Kimberly R.; Knutson, Keith L.

In: Journal of Immunology, Vol. 186, No. 12, 15.06.2011, p. 6905-6913.

Research output: Contribution to journalArticle

Krempski, James ; Karyampudi, Lavakumar ; Behrens, Marshall D. ; Erskine, Courtney L. ; Hartmann, Lynn ; Dong, Haidong M ; Goode, Ellen L ; Kalli, Kimberly R. ; Knutson, Keith L. / Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. In: Journal of Immunology. 2011 ; Vol. 186, No. 12. pp. 6905-6913.
@article{1f442e912f264a2eaf4f35606497bf3c,
title = "Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer",
abstract = "Within the ovarian cancer microenvironment, there are several mechanisms that suppress the actions of antitumor immune effectors. Delineating the complex immune microenvironment is an important goal toward developing effective immune-based therapies. A dominant pathway of immune suppression in ovarian cancer involves tumor-associated and dendritic cell (DC)-associated B7-H1. The interaction of B7-H1 with PD-1 on tumor-infiltrating T cells is a widely cited theory of immune suppression involving B7-H1 in ovarian cancer. Recent studies suggest that the B7-H1 ligand, programmed death receptor-1 (PD-1), is also expressed on myeloid cells, complicating interpretations of how B7-H1 regulates DC function in the tumor. In this study, we found that ovarian cancer-infiltrating DCs progressively expressed increased levels of PD-1 over time in addition to B7-H1. These dual-positive PD-1+ B7-H1 + DCs have a classical DC phenotype (i.e., CD11c +CD11b+CD8-), but are immature, suppressive, and respond poorly to danger signals. Accumulation of PD-1+B7-H1 + DCs in the tumor was associated with suppression of T cell activity and decreased infiltrating T cells in advancing tumors. T cell suppressor function of these DCs appeared to be mediated by T cell-associated PD-1. In contrast, ligation of PD-1 expressed on the tumor-associated DCs suppressed NF-κB activation, release of immune regulatory cytokines, and upregulation of costimulatory molecules. PD-1 blockade in mice bearing ovarian cancer substantially reduced tumor burden and increased effector Ag-specific T cell responses. Our results reveal a novel role of tumor infiltrating PD-1 +B7-H1+ DCs in mediating immune suppression in ovarian cancer.",
author = "James Krempski and Lavakumar Karyampudi and Behrens, {Marshall D.} and Erskine, {Courtney L.} and Lynn Hartmann and Dong, {Haidong M} and Goode, {Ellen L} and Kalli, {Kimberly R.} and Knutson, {Keith L}",
year = "2011",
month = "6",
day = "15",
doi = "10.4049/jimmunol.1100274",
language = "English (US)",
volume = "186",
pages = "6905--6913",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

AU - Krempski, James

AU - Karyampudi, Lavakumar

AU - Behrens, Marshall D.

AU - Erskine, Courtney L.

AU - Hartmann, Lynn

AU - Dong, Haidong M

AU - Goode, Ellen L

AU - Kalli, Kimberly R.

AU - Knutson, Keith L

PY - 2011/6/15

Y1 - 2011/6/15

N2 - Within the ovarian cancer microenvironment, there are several mechanisms that suppress the actions of antitumor immune effectors. Delineating the complex immune microenvironment is an important goal toward developing effective immune-based therapies. A dominant pathway of immune suppression in ovarian cancer involves tumor-associated and dendritic cell (DC)-associated B7-H1. The interaction of B7-H1 with PD-1 on tumor-infiltrating T cells is a widely cited theory of immune suppression involving B7-H1 in ovarian cancer. Recent studies suggest that the B7-H1 ligand, programmed death receptor-1 (PD-1), is also expressed on myeloid cells, complicating interpretations of how B7-H1 regulates DC function in the tumor. In this study, we found that ovarian cancer-infiltrating DCs progressively expressed increased levels of PD-1 over time in addition to B7-H1. These dual-positive PD-1+ B7-H1 + DCs have a classical DC phenotype (i.e., CD11c +CD11b+CD8-), but are immature, suppressive, and respond poorly to danger signals. Accumulation of PD-1+B7-H1 + DCs in the tumor was associated with suppression of T cell activity and decreased infiltrating T cells in advancing tumors. T cell suppressor function of these DCs appeared to be mediated by T cell-associated PD-1. In contrast, ligation of PD-1 expressed on the tumor-associated DCs suppressed NF-κB activation, release of immune regulatory cytokines, and upregulation of costimulatory molecules. PD-1 blockade in mice bearing ovarian cancer substantially reduced tumor burden and increased effector Ag-specific T cell responses. Our results reveal a novel role of tumor infiltrating PD-1 +B7-H1+ DCs in mediating immune suppression in ovarian cancer.

AB - Within the ovarian cancer microenvironment, there are several mechanisms that suppress the actions of antitumor immune effectors. Delineating the complex immune microenvironment is an important goal toward developing effective immune-based therapies. A dominant pathway of immune suppression in ovarian cancer involves tumor-associated and dendritic cell (DC)-associated B7-H1. The interaction of B7-H1 with PD-1 on tumor-infiltrating T cells is a widely cited theory of immune suppression involving B7-H1 in ovarian cancer. Recent studies suggest that the B7-H1 ligand, programmed death receptor-1 (PD-1), is also expressed on myeloid cells, complicating interpretations of how B7-H1 regulates DC function in the tumor. In this study, we found that ovarian cancer-infiltrating DCs progressively expressed increased levels of PD-1 over time in addition to B7-H1. These dual-positive PD-1+ B7-H1 + DCs have a classical DC phenotype (i.e., CD11c +CD11b+CD8-), but are immature, suppressive, and respond poorly to danger signals. Accumulation of PD-1+B7-H1 + DCs in the tumor was associated with suppression of T cell activity and decreased infiltrating T cells in advancing tumors. T cell suppressor function of these DCs appeared to be mediated by T cell-associated PD-1. In contrast, ligation of PD-1 expressed on the tumor-associated DCs suppressed NF-κB activation, release of immune regulatory cytokines, and upregulation of costimulatory molecules. PD-1 blockade in mice bearing ovarian cancer substantially reduced tumor burden and increased effector Ag-specific T cell responses. Our results reveal a novel role of tumor infiltrating PD-1 +B7-H1+ DCs in mediating immune suppression in ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=79959549102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959549102&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1100274

DO - 10.4049/jimmunol.1100274

M3 - Article

C2 - 21551365

AN - SCOPUS:79959549102

VL - 186

SP - 6905

EP - 6913

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -